UH Faculty, Staff, and Student Works
Permanent URI for this collectionhttps://hdl.handle.net/10657/22
The collection gathers research products generated by University of Houston faculty, staff, and students
Browse
Browsing UH Faculty, Staff, and Student Works by Author "Abraham, Carmela R."
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item Identification of novel small molecules that elevate Klotho expression(Biochemical Journal, 2013-06) King, Gwendalyn D.; Chen, CiDi; Huang, Mickey M.; Zeldich, Ella; Brazee, Patricia L.; Schyman, Eli R.; Robin, Maxime; Cuny, Gregory D.; Glicksman, Marcie A.; Abraham, Carmela R.The absence of Klotho (KL) from mice causes the development of disorders associated with human aging and decreased longevity, whereas increased expression prolongs lifespan. With age, KL protein levels decrease, and keeping levels consistent may promote healthier aging and be disease-modifying. Using the KL promoter to drive expression of luciferase, we conducted a high-throughput screen to identify compounds that activate KL transcription. Hits were identified as compounds that elevated luciferase expression at least 30%. Following validation for dose-dependent activation and lack of cytotoxicity, hit compounds were evaluated further in vitro by incubation with opossum kidney and Z310 rat choroid plexus cells, which express KL endogenously. All compounds elevated KL protein compared with control. To determine whether increased protein resulted in an in vitro functional change, we assayed FGF23 (fibroblast growth factor 23) signalling. Compounds G–I augmented ERK (extracellular-signal-regulated kinase) phosphorylation in FGFR (fibroblast growth factor receptor)-transfected cells, whereas co-transfection with KL siRNA (small interfering RNA) blocked the effect. These compounds will be useful tools to allow insight into the mechanisms of KL regulation. Further optimization will provide pharmacological tools for in vivo studies of KL.Item Lowering of amyloid beta peptide production with a small molecule inhibitor of amyloid-? precursor protein dimerization(American Journal of Neurodegenerative disease, 2012-04) So, Pauline P.L.; Zeldich, Ella; Seyb, Kathleen I.; Huang, Mickey M.; Concannon, John B.; King, Gwendalyn D.; Chen, CiDi; Cuny, Gregory D.; Glicksman, Marcie A.; Abraham, Carmela R.The amyloid ? precursor protein (APP) is a single-pass transmembrane glycoprotein that is ubiquitously expressed in many cell types, including neurons. Amyloidogenic processing of APP by ?- and ?-secretases leads to the production of amyloid-? (A?) peptides that can oligomerize and aggregate into amyloid plaques, a characteristic hallmark of Alzheimer’s disease (AD) brains. Multiple reports suggest that dimerization of APP may play a role in A? production; however, it is not yet clear whether APP dimers increase or decrease A? and the mechanism is not fully understood. To better understand the relationship between APP dimerization and production of A?, a high throughput screen for small molecule modulators of APP dimerization was conducted using APP-Firefly luciferase enzyme complementation to detect APP dimerization. Selected modulators identified from a compound library of 77,440 compounds were tested for their effects on A? generation. Two molecules that inhibited APP dimerization produced a reduction in A? levels as measured by ELISA. The inhibitors did not change sAPP? or ?-CTF levels, but lowered sAPP? levels, suggesting that blocking the dimerization is preventing the cleavage by ?-secretase in the amyloidogenic processing of APP. To our knowledge, this is the first High Throughput Screen (HTS) effort to identify small molecule modulators of APP dimerization. Inhibition of APP dimerization has previously been suggested as a therapeutic target in AD. The findings reported here further support that modulation of APP dimerization may be a viable means of reducing the production of A?.Item Small-molecule Klotho enhancers as novel treatment of neurodegeneration(Future Medicinal Chemistry, 2013-07) Abraham, Carmela R.; Chen, CiDi; Cuny, Gregory D.; Glicksman, Marcie A.; Zeldich, EllaThe majority of neurodegenerative diseases have an important age component, and thus, understanding the molecular changes that occur during normal aging of the brain is of utmost relevance. In search for the basis of the age-related cognitive decline found in humans, monkeys and rodents, we study the rhesus monkey. Surprisingly, there is no loss of neurons in aged monkey brains. However, we reported white matter and myelin abnormalities in aged monkeys, similar to those observed in Alzheimer’s disease and multiple sclerosis patients. In a microarray analysis comparing young and old monkey white matter, we discovered that Klotho is downregulated in the aged brain. We then asked whether there is a connection between the age-related cognitive decline, myelin abnormalities and Klotho downregulation. If such a connection is found, compounds that upregulate Klotho expression could become of therapeutic interest for the treatment of multiple sclerosis, and perhaps even Alzheimer’s disease.